MP37-09 LONG-TERM OUTCOMES OF DA VINCI SP® RADICAL PROSTATECTOMY: EXPERIENCE AND TECHNICAL SUGGESTIONS OF a REFERRAL CENTER

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy I (MP37)1 May 2024MP37-09 LONG-TERM OUTCOMES OF DA VINCI SP® RADICAL PROSTATECTOMY: EXPERIENCE AND TECHNICAL SUGGESTIONS OF a REFERRAL CENTER Marcio Covas Moschovas, Sarah Kind, Shady Saikali, Marco Sandri, Ahmed Gamal, Jaber Abdel, Sumeet Reddy, Travis Rogers, Roshane Perera, and Vipul Patel Marcio Covas MoschovasMarcio Covas Moschovas , Sarah KindSarah Kind , Shady SaikaliShady Saikali , Marco SandriMarco Sandri , Ahmed GamalAhmed Gamal , Jaber AbdelJaber Abdel , Sumeet ReddySumeet Reddy , Travis RogersTravis Rogers , Roshane PereraRoshane Perera , and Vipul PatelVipul Patel View All Author Informationhttps://doi.org/10.1097/01.JU.0001008948.02935.01.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Several centers described outcomes of Robotic-assisted Radical Prostatectomy (RARP) using the da Vinci SP® since its first FDA approval at the end of 2018. However, despite the high number of manuscripts and potential benefits described by some authors, the SP-RARP long-term functional and oncological outcomes are still lacking in the literature. In this scenario, we described our functional and oncological outcomes after four years of using this platform. METHODS: We reviewed the data of 122 patients with prostate cancer who underwent radical prostatectomy with the SP robot from June 2019 to July 2023, assessing perioperative results, pathology reports, long-term erection and continence recovery, and oncological outcomes. Medians and interquartile ranges (IQR) and frequencies and proportions were reported for continuous and categorical variables, respectively. RESULTS: Median follow-up is 35.8 months (23.8-36.5). The cohort had a median age of 62 years old (57-68), PSA of 5.8 (4.3-8.1), preoperative SHIM of 20 (14-25), AUA of 7 (3-11), and BMI of 27 (24.7-29.4). The median total operative time was 114 minutes (104-124), and the console time was 80 minutes (75-90). No intraoperative complications were reported. Median prostate weight was 48.5 grams (41-58). The overall positive surgical margins (PSM) rate was 13.9% (4.9% were pT2 and 9% were pT3). Overall, in patients who received full nerve-sparing and had a SHIM score >20, 59% achieved a trifecta (potent, continent, and PSA control). The median time to biochemical recurrence was 31 months (17.4-41.7) in 6.5% of the patients. CONCLUSIONS: This is the first study to report trifecta outcomes of radical prostatectomy with the da Vinci SP. The patients had optimal continence recovery and potency outcomes in candidates for full nerve-sparing are acceptable, but early potency recovery seems slower than in our multiport series. We had a small percentage of biochemical recurrence in the follow-up period, and most patients were pT3 in the final pathology. However, this robot has only five years of FDA clearance, and we still need a longer follow-up to achieve further oncological conclusions. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e605 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Marcio Covas Moschovas More articles by this author Sarah Kind More articles by this author Shady Saikali More articles by this author Marco Sandri More articles by this author Ahmed Gamal More articles by this author Jaber Abdel More articles by this author Sumeet Reddy More articles by this author Travis Rogers More articles by this author Roshane Perera More articles by this author Vipul Patel More articles by this author Expand All Advertisement PDF downloadLoading ...